PPTA Twitter

PlasmaProteins #TBT to PPTA’s interview with Val Bias, the former CEO of @NHF_Hemophilia to get a glimpse into the future for those living with #bleedingdisorders . Read more: bit.ly/2DZQ7Np pic.twitter.com/Fq9dRMJLLH
2 days ago.
PlasmaProteins “Ultimately, what drives my colleagues on the Board, my company, and the staff at PPTA is a focus on patients...” Karen Etchberger, of @CSLBehring , reflects on her election as Chair of @plasmaproteins Global Board of Directors. bit.ly/2u61VeZ pic.twitter.com/QKhDPwL1e0
9 days ago.

FDA Posts Public Meeting Documents

FDA has posted the slides and transcript of the FDA Public Meeting on the Final Assessment of the Program for Enhanced Review Transparency and Communication in PDUFA V, held March 27, 2017, in Silver Spring, Md., as well as other documents related to evaluation of the PDUFA V Program.

Copyright © 2018 PPTA. All rights reserved. (202) 789-3100